ERBB2 and breast cancer: Upregulation of miR-125 and consequent inhibition of TINCR suppresses EMT and migration ability by directly binding miRNA to SNAI1. These results suggest that TINCR/miR-125/SNAI1 would be a promising target to overcome TRA resistance in HER2 + BC [222].